Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 9496 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#9496, RRID:AB_561381
- Product name
- Cleaved Caspase-8 (Asp391) (18C8) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Rabbit
- Storage
- -20°C
Submitted references TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer.
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.
Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
Shen W, Chang A, Wang J, Zhou W, Gao R, Li J, Xu Y, Luo X, Xiang R, Luo N, Stupack DG
Oncogenesis 2015 Oct 26;4:e173
Oncogenesis 2015 Oct 26;4:e173
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
Jinesh G G, Chunduru S, Kamat AM
Journal of leukocyte biology 2012 Jul;92(1):233-44
Journal of leukocyte biology 2012 Jul;92(1):233-44
Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.
Thomé CH, dos Santos GA, Ferreira GA, Scheucher PS, Izumi C, Leopoldino AM, Simão AM, Ciancaglini P, de Oliveira KT, Chin A, Hanash SM, Falcão RP, Rego EM, Greene LJ, Faça VM
Molecular & cellular proteomics : MCP 2012 Dec;11(12):1898-912
Molecular & cellular proteomics : MCP 2012 Dec;11(12):1898-912
Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
Jane EP, Premkumar DR, Pollack IF
Molecular cancer therapeutics 2011 Jan;10(1):198-208
Molecular cancer therapeutics 2011 Jan;10(1):198-208
A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
D'Agostino L, Giordano A
Oncotarget 2011 Dec;2(12):1055-74
Oncotarget 2011 Dec;2(12):1055-74
A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
D'Agostino L, Giordano A
Oncotarget 2011 Dec;2(12):1055-74
Oncotarget 2011 Dec;2(12):1055-74
NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
Biton S, Ashkenazi A
Cell 2011 Apr 1;145(1):92-103
Cell 2011 Apr 1;145(1):92-103
No comments: Submit comment
No validations: Submit validation data